Eupraxia Pharmaceuticals (EPRX) Live Share Price, Invest From India

Eupraxia Pharmaceuticals Stock Performance

as on October 22, 2026 at 6:59 am IST

Day's Low
Day's High
$7.55
Day's Price Range
$7.76
$7.72
2.20%
Downside
0.52%
Upside
52 Week's Low
52 Week's High
$5.25
52-Week Price Range
$9.32
$7.72
31.99%
Downside
20.73%
Upside

Eupraxia Pharmaceuticals share price movements today

Previous Close: $7.59
Open: $7.66
Volume: 516.0K
Market Cap: $437.4M
Day's Low - High: $7.55 - $7.76
52 Week Low - High: $5.25 - $9.32

Eupraxia Pharmaceuticals Historical Returns

1 Month Return: -19 %
3 Month Return: + 11.38 %
1 Year Return: + 18.2 %
3 Year Return: 0 %
5 Year Return: 0 %

Eupraxia Pharmaceuticals Stock Fundamentals & Key Indicators

Check Eupraxia Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$437.4M

EPS (TTM)

-1.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.49

Industry PE ratio

-7.03

PEG Ratio

0.29

EBITDA

-55.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-45.29%

Eupraxia Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eupraxia Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Eupraxia Pharmaceuticals	StrongBuy	$437.4M	NA	-6.49	0.00%	0.00%
Moderna	Neutral	$87.0B	-31.87%	-27.32	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$126.7B	170.61%	28.85	86.04%	0.00%
Regeneron	Buy	$81.4B	38.98%	18.88	84.86%	0.47%

Stock Returns calculator for Eupraxia Pharmaceuticals Stock including INR - Dollar returns

The Eupraxia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Eupraxia Pharmaceuticals investment value today

Current value as on today

₹1,40,882

Returns

₹40,882

(+40.88%)

Returns from Eupraxia Pharmaceuticals Stock

₹31,293 (+31.29%)

Dollar Impact

₹9,590 (+9.59%)

Analyst Recommendation on Eupraxia Pharmaceuticals Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Eupraxia Pharmaceuticals. Average target price of $16.35

Eupraxia Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Eupraxia Pharmaceuticals.

What analysts predicted

52.78%UPSIDE

Target Price

$16.35

Current Price

$7.72

Analyzed by

6 Analysts

High

$25

Target

$16.35

Low

$14

Eupraxia Pharmaceuticals target price $16.35, a slight upside of 52.78% compared to current price of $7.72. According to 6 analysts rating.

Indian Investors' Interest in Eupraxia Pharmaceuticals Stock

Search interest for Eupraxia Pharmaceuticals Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 22, 2026 to October 22, 2026

Change:11% versus previous 30 day period

Eupraxia Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-6	-6	-6	-7	-7	-8	-6	-16	-15	-17
EBITDA	-5	-4	-4	-7	-4	-6	-6	-16	-15	-17
Interest Expense	0	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-	-6	-5	-7	-6	-8	-6	-16	-12	-14
Income Tax Expense	0	0	-	0	0	0	0	0	0	0
Net Income	-6	-4	-5	-7	-6	-8	-6	-16	-12	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Eupraxia Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Mar 2024	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-4	-12	-6	-2	-18	-23	-28	-25	-39
EBITDA	-4	-11	-5	-2	-21	-22	-28	-23	-38
Interest Expense	0	0	1	1	1	1	1	0	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-14	-7	-4	-23	-23	-28	-24	-39
Income Tax Expense	-	-	-	-	-	-	0	-	0
Net Income	-4	-13	-7	-3	-22	-23	-28	-24	-39
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Eupraxia Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-6	-4	-4	-7	-6	-8	-4	-16	-12	-14
Operating Cash Flow	-6	-7	-7	-5	-6	-8	-3	-9	-9	-12
Investing Cash Flow	0	0	0	0	0	0	0	0	-78	0
Financing Cash Flow	23	-4	-3	31	0	0	52	1	67	7
Change in Cash	11	-12	-10	24	-5	-7	49	-9	-20	-5

Eupraxia Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Mar 2024	Dec 2024	Dec 2025
Net Income	-4	-14	-7	-4	-23	-23	-28	-25	-38
Operating Cash Flow	-5	-8	-5	0	-14	-18	-21	-29	-29
Investing Cash Flow	0	0	-1	0	-14	8	0	0	0
Financing Cash Flow	9	5	7	0	49	13	21	45	77
Change in Cash	3	-3	0	-1	20	3	0	13	45

Global Institutional Holdings in Eupraxia Pharmaceuticals

Check out the Institutions with significant holdings in Eupraxia Pharmaceuticals.

Funds	Holdings
Michael Rockefeller	1.13%
Dennis J Purcell	0.49%
Dynamic	0.08%
iShares	0.07%
State Street	0.07%

See all

Eupraxia Pharmaceuticals News & Key Events

Insights on Eupraxia Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, EPRX stock has moved up by 15.2%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 780.6% return, outperforming this stock by 742.3%

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the discovery, advancement, and commercialization of innovative technologies. Its flagship compound, EP-104IAR, is currently in a Phase II clinical trial, targeting both critical unmet medical needs and pain management for knee osteoarthritis. This promising candidate is also being developed for veterinary use, specifically for canine and equine osteoarthritis. Eupraxia's broader development portfolio includes EP-201, an antibiotic aimed at preventing post-surgical site infections, and EP-105, an extended-release anesthetic designed for extended post-operative pain relief. Furthermore, the company is actively developing product candidates for oncology applications. Established in 2011 and headquartered in Victoria, Canada, Eupraxia Pharmaceuticals Inc. was formerly known as Plaza Capital Partners Inc. until its renaming in May 2012.

Organisation	Eupraxia Pharmaceuticals
Headquarters	2067 Cadboro Bay Road, Victoria, BC, V8R 5G4, CA
Industry	Biotechnology
CEO	James A. Helliwell

Key Management of Eupraxia Pharmaceuticals

Name	Title
Dr. James A. Helliwell FRCPC, M.D.	CEO & Director
Mr. Alexander John Rothwell Eng., M.B.A.	Chief Financial Officer
Mr. Paul Anthony Brennan B.Sc., M.Sc.	Chief Corporate Development Officer
Ms. Wajida Leclerc B.A., CCP, CHRP	Executive Vice President Corporate Services & People
Mr. Alex Therien	Executive VP of R&D
Dr. Jeymi Tambiah M.S.	Chief Medical Officer
Dr. Jeffrey Millard Ph.d.	Executive Vice President of Technical Operations

FAQs

What is Eupraxia Pharmaceuticals share price today?

Eupraxia Pharmaceuticals share price today is $7.72 as on October 22, 2026 at 1:29 am IST at the close of the market. Eupraxia Pharmaceuticals share today touched a day high of $7.76 and a low of $7.55.

What is the 52 week high and 52 week low for Eupraxia Pharmaceuticals share?

Eupraxia Pharmaceuticals share touched a 52 week high of $9.32 on January 21, 2026 and a 52 week low of $5.25 on November 6, 2025. Eupraxia Pharmaceuticals stock price today i.e. October 22, 2026 at 1:29 am IST is closed at $7.72,which is 17.17% down from its 52 week high and 47.05% up from its 52 week low.

What is Eupraxia Pharmaceuticals's market capitalisation today?

Eupraxia Pharmaceuticals market capitalisation is $0.00T as on October 22, 2026 at 1:29 am IST.

How to invest in Eupraxia Pharmaceuticals Stock (EPRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eupraxia Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Eupraxia Pharmaceuticals Stock (EPRX) from India?

Indian investors can start investing in Eupraxia Pharmaceuticals (EPRX) shares with as little as ₹94.449996948242 or $1 (as of October 22, 2026 at 4:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.50 in Eupraxia Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on October 22, 2026 at 4:44 am IST). Based on Eupraxia Pharmaceuticals share’s latest price of $7.72 as on October 22, 2026 at 1:29 am IST, you will get 1.2953 shares of Eupraxia Pharmaceuticals. Learn more about fractional shares .